Status:
RECRUITING
Comparing Conventional Continuous Ambulatory Peritoneal Dialysis Prescription (C-CAPD) With Modified-CAPD (M-CAPD) Prescription in Children With End-stage Kidney Disease From Low-resource Settings
Lead Sponsor:
National University Health System, Singapore
Collaborating Sponsors:
University of the Philippines Manila - Philippine General Hospital
Hospital Tuanku Jaafar, Seremban, Negeri Sembilan
Conditions:
Children on Chronic Peritoneal Dialysis
Eligibility:
All Genders
2-18 years
Phase:
NA
Brief Summary
This study aims to compare modified CAPD (M-CAPD) and conventional CAPD (C-CAPD) in terms of delivering high-quality, goal-directed PD as well as avoiding resource wastage in prevalent ESKD patients a...
Detailed Description
Background and Rationale Peritoneal dialysis (PD) is the primary kidney replacement therapy (KRT) for children with end-stage kidney disease (ESKD), particularly in low-resource settings. In these set...
Eligibility Criteria
Inclusion
- CKD 5D who have been on peritoneal dialysis for at least three months.
Exclusion
- Patients with BSA of ≥1.5 m2,
- Evidence of mechanical causes of low ultrafiltration capacity (hernia, peri-catheter, or genital leaks, pleuroperitoneal communication),
- Peritoneal membrane failure (encapsulating peritoneal sclerosis),
- Recent episode of peritonitis (within two months)
- Those who have been on hemodialysis before switching to PD in the last three weeks.
Key Trial Info
Start Date :
November 18 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2026
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT07134595
Start Date
November 18 2024
End Date
June 30 2026
Last Update
August 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Philippine General Hospital
Manila, Ermita, Philippines, 1000 Metro Manila